The PE Ratio as of November 2024 (TTM) for Orgenesis Inc. (ORGS) is -0.05

According to Orgenesis Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.05. This represents a change of -97.30% compared to the average of -1.85 of the last 4 quarters.

Orgenesis Inc. (ORGS) Historical PE Ratio (quarterly & annually)

How has ORGS PE Ratio performed in the past?

The mean historical PE Ratio of Orgenesis Inc. over the last ten years is -35.18. The current -0.05 PE Ratio has changed -85.79% with respect to the historical average. Over the past ten years (40 quarters), ORGS's PE Ratio was at its highest in in the February 2016 quarter at 378.13. The PE Ratio was at its lowest in in the March 2021 quarter at -1582.48.

Orgenesis Inc. (ORGS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Orgenesis Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Orgenesis Inc. (ORGS) Average PE Ratio

How has ORGS PE Ratio performed in the past?

The current PE Ratio of Orgenesis Inc. (ORGS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Orgenesis Inc. (ORGS) PE Ratio vs. Peers

How is ORGS’s PE Ratio compared to its peers?

Orgenesis Inc.’s PE Ratio is greater than TFF Pharmaceuticals, Inc. (-0.08), less than Oncorus, Inc. (-0.04), greater than Quoin Pharmaceuticals, Ltd. (-0.33), greater than Apexigen, Inc. (-0.24), greater than Aerovate Therapeutics, Inc. (-0.91), greater than Adagene Inc. (-3.02), greater than Acrivon Therapeutics, Inc. Common Stock (-3.24), greater than Rezolute, Inc. (-4.94), greater than AN2 Therapeutics, Inc. (-0.66), less than NeuroBo Pharmaceuticals, Inc. (0), greater than Indaptus Therapeutics, Inc. (-0.87), greater than Pasithea Therapeutics Corp. (-0.64), less than Lixte Biotechnology Holdings, Inc. (-0.00), greater than Eliem Therapeutics, Inc. (-0.92), greater than Design Therapeutics, Inc. (-2.42), greater than Tango Therapeutics, Inc. (-6.66), greater than Talaris Therapeutics, Inc. (-3.45), greater than Achilles Therapeutics plc (-0.53), greater than null (-0.64),

Build a custom stock screener for Orgenesis Inc. (ORGS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orgenesis Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orgenesis Inc. (ORGS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orgenesis Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.